Figure 4From: Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines marketsTimeline of WHO Prequalification Programme and US FDA approvals of first-line fixed-dose combination ARVs.Back to article page